PXD026079
PXD026079 is an original dataset announced via ProteomeXchange.
Dataset Summary
Title | Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection |
Description | Type I interferons (IFN-I) exert pleiotropic biological effects during viral infections, balancing virus control versus immune-mediated pathologies and have been successfully employed for the treatment of viral diseases. Humans express twelve IFN-alpha (α) subtypes, which activate downstream signalling cascades and result in distinct patterns of immune responses and differential antiviral responses. Inborn errors in type I IFN immunity and the presence of anti- IFN autoantibodies account for very severe courses of COVID-19, therefore, early administration of type I IFNs may be protective against life-threatening disease. Here we comprehensively analysed the antiviral activity of all IFNα subtypes against SARS-CoV-2 to identify the underlying immune signatures and explore their therapeutic potential. Prophylaxis of primary human airway epithelial cells (hAEC) with different IFNα subtypes during SARS-CoV-2 infection uncovered distinct functional classes with high, intermediate and low antiviral IFNs. In particular IFNα5 showed superior antiviral activity against SARS-CoV-2 infection. Dose-dependency studies further displayed additive effects upon co-administered with the broad antiviral drug remdesivir in cell culture. Transcriptomics of IFN-treated hAEC revealed different transcriptional signatures, uncovering distinct, intersecting and prototypical genes of individual IFNα subtypes. Global proteomic analyses systematically assessed the abundance of specific antiviral key effector molecules which are involved in type I IFN signalling pathways, negative regulation of viral processes and immune effector processes for the potent antiviral IFNα5. Taken together, our data provide a systemic, multi-modular definition of antiviral host responses mediated by defined type I IFNs. This knowledge shall support the development of novel therapeutic approaches against SARS-CoV-2. |
HostingRepository | PRIDE |
AnnounceDate | 2022-02-09 |
AnnouncementXML | Submission_2022-06-05_14:54:54.355.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD026079 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Thilo Bracht |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | iodoacetamide derivatized residue |
Instrument | Q Exactive HF |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
---|---|---|---|
0 | 2021-05-18 08:42:42 | ID requested | |
1 | 2022-02-09 07:45:05 | announced | |
⏵ 2 | 2022-06-05 14:54:55 | announced | 2022-06-05: Updated publication reference for PubMed record(s): 35131898. |
Publication List
Schuhenn J, Meister TL, Todt D, Bracht T, Schork K, Billaud JN, Elsner C, Heinen N, Karakoese Z, Haid S, Kumar S, Brunotte L, Eisenacher M, Di Y, Lew J, Falzarano D, Chen J, Yuan Z, Pietschmann T, Wiegmann B, Uebner H, Taube C, Le-Trilling VTK, Trilling M, Krawczyk A, Ludwig S, Sitek B, Steinmann E, Dittmer U, Lavender KJ, Sutter K, Pfaender S, subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. Proc Natl Acad Sci U S A, 119(8):(2022) [pubmed] |
Keyword List
ProteomeXchange project tag: Sars-cov-2, Covid-19 |
submitter keyword: Type I IFN, IFNα subtypes, SARS-CoV-2, COVID-19, antiviral treatment, therapy, ISG |
Contact List
Thilo Bracht | |
---|---|
contact affiliation | Ruhr-University Bochum Medizinisches Proteom-Center Clinical Proteomics - Translational Proteomics and University Hospital Knappschaftskrankenhaus Bochum Department of Anesthesia, Intensive Care Medicine, and Pain Therapy |
contact email | thilo.bracht@rub.de |
lab head | |
Thilo Bracht | |
contact affiliation | Clinical Proteomics |
contact email | thilo.bracht@rub.de |
dataset submitter |
Full Dataset Link List
Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD026079 |
PRIDE project URI |
Repository Record List
[ + ]